201 related articles for article (PubMed ID: 3346076)
1. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity.
Peterson EM; Zhong GM; Carlson E; de la Maza LM
Infect Immun; 1988 Apr; 56(4):885-91. PubMed ID: 3346076
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
Qu Z; Cheng X; de la Maza LM; Peterson EM
Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
[TBL] [Abstract][Full Text] [Related]
3. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
[TBL] [Abstract][Full Text] [Related]
4. Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.
Peterson EM; Cheng X; Pal S; de la Maza LM
Infect Immun; 1993 Feb; 61(2):498-503. PubMed ID: 8423079
[TBL] [Abstract][Full Text] [Related]
5. The role of lipopolysaccharide in the exposure of protective antigenic sites on the major outer membrane protein of Chlamydia trachomatis.
Vretou E; Psarrou E; Spiliopoulou D
J Gen Microbiol; 1992 Jun; 138(6):1221-7. PubMed ID: 1382112
[TBL] [Abstract][Full Text] [Related]
6. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
Peterson EM; Cheng X; Motin VL; de la Maza LM
Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
[TBL] [Abstract][Full Text] [Related]
7. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.
Brossay L; Villeneuve A; Paradis G; Coté L; Mourad W; Hébert J
Infect Immun; 1994 Feb; 62(2):341-7. PubMed ID: 7507888
[TBL] [Abstract][Full Text] [Related]
8. Immunologic characterization of a cloned fragment containing the species-specific epitope from the major outer membrane protein of Chlamydia trachomatis.
Toye B; Zhong GM; Peeling R; Brunham RC
Infect Immun; 1990 Dec; 58(12):3909-13. PubMed ID: 1701415
[TBL] [Abstract][Full Text] [Related]
9. Complement dependent in vitro neutralization of Chlamydia trachomatis by a subspecies-specific monoclonal antibody.
Fedorko DP; Clark RB; Nachamkin I; Dalton HP
Med Microbiol Immunol; 1987; 176(4):225-8. PubMed ID: 3614096
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.
Peterson EM; de la Maza LM; Brade L; Brade H
Infect Immun; 1998 Aug; 66(8):3848-55. PubMed ID: 9673271
[TBL] [Abstract][Full Text] [Related]
11. In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein.
Peeling R; Maclean IW; Brunham RC
Infect Immun; 1984 Nov; 46(2):484-8. PubMed ID: 6209221
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.
Stephens RS; Tam MR; Kuo CC; Nowinski RC
J Immunol; 1982 Mar; 128(3):1083-9. PubMed ID: 7035557
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Chlamydia trachomatis antigens with monoclonal and polyclonal antibodies.
Maclean IW; Peeling RW; Brunham RC
Can J Microbiol; 1988 Feb; 34(2):141-7. PubMed ID: 2456851
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of monoclonal antibodies to Chlamydia trachomatis.
Kumar A; Mittal A
Hybridoma (Larchmt); 2006 Oct; 25(5):293-9. PubMed ID: 17044785
[TBL] [Abstract][Full Text] [Related]
16. Antigenic topology of chlamydial PorB protein and identification of targets for immune neutralization of infectivity.
Kawa DE; Stephens RS
J Immunol; 2002 May; 168(10):5184-91. PubMed ID: 11994474
[TBL] [Abstract][Full Text] [Related]
17. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies.
Peterson EM; Cheng X; Markoff BA; Fielder TJ; de la Maza LM
Infect Immun; 1991 Nov; 59(11):4147-53. PubMed ID: 1718870
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody neutralization of unmanipulated Chlamydia trachomatis serovar A infection of human epithelioid cells (A-431).
Barsoum IS; Goodman TA; Hardin LK; Colley DG
Med Microbiol Immunol; 1989; 178(2):113-20. PubMed ID: 2733633
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis.
Lu C; Holland MJ; Gong S; Peng B; Bailey RL; Mabey DW; Wu Y; Zhong G
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2551-9. PubMed ID: 22427578
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the humoral response induced by a synthetic peptide of the major outer membrane protein of Chlamydia trachomatis serovar B.
Villeneuve A; Brossay L; Paradis G; Hébert J
Infect Immun; 1994 Aug; 62(8):3547-9. PubMed ID: 8039926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
